Kim KH - Search Results

1

Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma.

Kim KH, Cho S, Jeong Y, Baek ES, Lee C, Ryu HJ, Noh YS, Hong YH, Chung KY, Roh MR, Oh BH, Kim CG, Jung M, Shin SJ. Kim KH, et al. Among authors: kim cg. Oncologist. 2024 Jun 3;29(6):e811-e821. doi: 10.1093/oncolo/oyae018. Oncologist. 2024. PMID: 38470950 Free PMC article.

2

First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma.

Kim CG, Kim M, Hwang J, Kim ST, Jung M, Kim KH, Kim KH, Chang JS, Koom WS, Roh MR, Chung KY, Kim TM, Kim SK, Lee J, Shin SJ. Kim CG, et al. Among authors: kim st, kim m, kim sk, kim tm, kim kh. J Am Acad Dermatol. 2022 Nov;87(5):989-996. doi: 10.1016/j.jaad.2022.07.057. Epub 2022 Sep 6. J Am Acad Dermatol. 2022. PMID: 36068115

3

A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13).

Kim KH, Jung M, Lee HJ, Lee SJ, Kim M, Ahn MS, Choi MY, Lee NR, Shin SJ; Korean Cancer Study Group (KCSG). Kim KH, et al. Among authors: kim m. Eur J Cancer. 2023 Nov;193:113312. doi: 10.1016/j.ejca.2023.113312. Epub 2023 Aug 28. Eur J Cancer. 2023. PMID: 37741071 Free article.

4

Immunogenicity and Safety of Vaccines against Coronavirus Disease in Actively Treated Patients with Solid Tumors: A Prospective Cohort Study.

Baek YJ, Lee YJ, Park SR, Kim KH, Beom SH, Lee CK, Shin SJ, Rha SY, Kim S, Lee KH, Kim JH, Jeong SJ, Ku NS, Choi JY, Yeom JS, Jung M, Ahn JY. Baek YJ, et al. Among authors: kim s, kim kh, kim jh. Cancer Res Treat. 2023 Jul;55(3):746-757. doi: 10.4143/crt.2022.1541. Epub 2023 Feb 9. Cancer Res Treat. 2023. PMID: 36758955 Free PMC article.

5

Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea.

Hong M, Choi M, Lee J, Kim KH, Kim H, Lee CK, Kim HS, Rha SY, Pih GY, Choi YJ, Jung DH, Park JC, Shin SK, Lee SK, Lee YC, Cho M, Kim YM, Kim HI, Cheong JH, Hyung WJ, Shin J, Jung M. Hong M, et al. Among authors: kim h, kim hi, kim ym, kim hs, kim kh. J Gastric Cancer. 2023 Oct;23(4):574-583. doi: 10.5230/jgc.2023.23.e36. J Gastric Cancer. 2023. PMID: 37932224 Free PMC article.

6

p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer.

Bae HJ, Kang SK, Kwon WS, Jeong I, Park S, Kim TS, Kim KH, Kim H, Jeong HC, Chung HC, Rha SY. Bae HJ, et al. Among authors: kim ts, kim h, kim kh. Biochem Pharmacol. 2021 Jan;183:114320. doi: 10.1016/j.bcp.2020.114320. Epub 2020 Nov 6. Biochem Pharmacol. 2021. PMID: 33161023

7

A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.

Kim KH, Lim SM, Ahn HK, Lee YG, Lee KW, Ahn MJ, Keam B, Kim HR, Lee HW, An HJ, Kim JS. Kim KH, et al. Among authors: kim js, kim hr. Cancer Res Treat. 2024 Jan;56(1):37-47. doi: 10.4143/crt.2023.433. Epub 2023 Jul 20. Cancer Res Treat. 2024. PMID: 37475136 Free PMC article. Clinical Trial.

8

Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer.

Kang SK, Bae HJ, Kwon WS, Kim TS, Kim KH, Park S, Yu SY, Hwang J, Park J, Chung HC, Rha SY. Kang SK, et al. Among authors: kim ts, kim kh. Cell Oncol (Dordr). 2021 Dec;44(6):1387-1403. doi: 10.1007/s13402-021-00647-4. Epub 2021 Nov 18. Cell Oncol (Dordr). 2021. PMID: 34791636

9

Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.

Jeong I, Kang SK, Kwon WS, Kim HJ, Kim KH, Kim HM, Lee A, Lee SK, Bogenrieder T, Chung HC, Rha SY. Jeong I, et al. Among authors: kim hj, kim hm, kim kh. J Cell Mol Med. 2018 Dec;22(12):5899-5908. doi: 10.1111/jcmm.13859. Epub 2018 Sep 24. J Cell Mol Med. 2018. PMID: 30247804 Free PMC article.

10

Applying a Novel Optical Technique for Residual Cancer Detection with Accuracy Evaluation: A Cornerstone for Field Implementation.

Oh BH, Kim KH. Oh BH, et al. Among authors: kim kh. Br J Dermatol. 2024 Jun 11:ljae246. doi: 10.1093/bjd/ljae246. Online ahead of print. Br J Dermatol. 2024. PMID: 38860490 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,259 results

Search Page